AU1022999A - 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs - Google Patents

1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs

Info

Publication number
AU1022999A
AU1022999A AU10229/99A AU1022999A AU1022999A AU 1022999 A AU1022999 A AU 1022999A AU 10229/99 A AU10229/99 A AU 10229/99A AU 1022999 A AU1022999 A AU 1022999A AU 1022999 A AU1022999 A AU 1022999A
Authority
AU
Australia
Prior art keywords
analogs
dihydroxy
dialkyl
vitamin
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10229/99A
Other languages
English (en)
Inventor
Percy Sarwood Manchand
Milan Radoje Uskokovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU1022999A publication Critical patent/AU1022999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU10229/99A 1997-09-08 1998-09-02 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs Abandoned AU1022999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5813297P 1997-09-08 1997-09-08
US60058132 1997-09-08
PCT/EP1998/005571 WO1999012894A1 (en) 1997-09-08 1998-09-02 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs

Publications (1)

Publication Number Publication Date
AU1022999A true AU1022999A (en) 1999-03-29

Family

ID=22014900

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10229/99A Abandoned AU1022999A (en) 1997-09-08 1998-09-02 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs

Country Status (9)

Country Link
US (3) US6492353B1 (https=)
EP (1) EP1015423B1 (https=)
JP (1) JP4219553B2 (https=)
AT (1) ATE238986T1 (https=)
AU (1) AU1022999A (https=)
CA (1) CA2303248A1 (https=)
DE (1) DE69814109T2 (https=)
ES (1) ES2196614T3 (https=)
WO (1) WO1999012894A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19916419B4 (de) * 1999-04-08 2005-06-16 Schering Ag Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose
AU2001247619A1 (en) * 2000-03-27 2001-10-08 Wisconsin Alumni Research Foundation Vitamin d compounds used to stabilize kidney transplants
KR100637564B1 (ko) * 2001-01-26 2006-10-20 추가이 세이야쿠 가부시키가이샤 대사 조절자로서 유용한 말로닐-코에이 데카르복실라제억제제
WO2002094247A2 (en) * 2001-05-22 2002-11-28 Bioxell S.P.A. Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
MXPA04002640A (es) * 2001-09-21 2004-06-07 Hoffmann La Roche Esteres de analogos de 3-desoxi-vitamina d3.
US20050107350A1 (en) * 2003-08-22 2005-05-19 Pharmacia Corporation Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
JP2007506765A (ja) * 2003-09-24 2007-03-22 ビオクセル エッセ ピ ア １，３−ジアシル化２６，２７−アルキル／ハロアルキルビタミンｄ３化合物及びその使用方法
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CA2586679A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
JP4961562B2 (ja) * 2005-03-04 2012-06-27 国立大学法人 東京医科歯科大学 １９−ノルビタミンｄ誘導体
WO2007039322A1 (en) * 2005-09-19 2007-04-12 Bioxell Spa Use of vitamin d3 compounds for the treatment of uveitis
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
EP2621588A4 (en) * 2010-09-27 2014-09-03 Microdose Therapeutx Inc METHODS AND COMPOSITIONS FOR TREATING DISEASE USING INHALATION
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
KR0144358B1 (ko) * 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US5401731A (en) * 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
ATE143007T1 (de) 1991-07-05 1996-10-15 Duphar Int Res Vitamin-d derivat, verfahren zu dessen herstellung sowie zwischenprodukte dafür
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
DE69304279T2 (de) * 1992-05-20 1997-02-20 Hoffmann La Roche Fluorierte Analoge Vitamins D3
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
IL107185A (en) 1992-10-06 1998-02-22 Schering Ag Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
PT972762E (pt) * 1993-07-09 2004-02-27 Theramex Novos analogos estruturais da vitamina d
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
ES2144239T3 (es) * 1995-06-14 2000-06-01 Schering Ag Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
AU743514B2 (en) * 1997-05-16 2002-01-24 Women & Infants Hospital Cyclic ether vitamin D3 compounds, 1alpha (OH) 3-EPI-vitamin D3 compounds and uses thereof

Also Published As

Publication number Publication date
US20030083319A1 (en) 2003-05-01
EP1015423B1 (en) 2003-05-02
ES2196614T3 (es) 2003-12-16
EP1015423A1 (en) 2000-07-05
US6492353B1 (en) 2002-12-10
ATE238986T1 (de) 2003-05-15
DE69814109T2 (de) 2004-02-26
DE69814109D1 (de) 2003-06-05
US20040167105A1 (en) 2004-08-26
JP2001515881A (ja) 2001-09-25
CA2303248A1 (en) 1999-03-18
WO1999012894A1 (en) 1999-03-18
JP4219553B2 (ja) 2009-02-04

Similar Documents

Publication Publication Date Title
EP0911321A3 (en) Compounds for the treatment of osteoporosis
AU1022999A (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
LU91145I9 (https=)
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
GB9813540D0 (en) Chemical compounds
AP9801269A0 (en) Prostaglandin agonists.
DE60038038D1 (en) Phosphonatverbindungen
HK1038744A1 (zh) 用於治療炎性疾病的化合物
MXPA04004498A (es) Derivados de n-adamantilmetil e intermediarios como composiciones farmaceuticas y procesos para su preparacion.
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
MX9805253A (es) Antagonistas del receptor de vitronectina.
NZ503308A (en) Alpha-ketoamide multicatalytic protease inhibitors
GB0013737D0 (en) Novel compounds
PL345561A1 (en) Substituted benzoylcyclohexandiones
CA2225903A1 (en) Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
GB9712966D0 (en) Novel chalcones
AU7084196A (en) Process for preparing a 2-chloro-5-chloromethyl-thiazole compound
AU7520898A (en) Tetrahydropyrido compounds
AU4916597A (en) Semi-synthetic studies toward didemnin analogues
AU623805B2 (en) New use of anti-progestomimetic compounds
AU6826700A (en) Ceramide analogs, process for their preparation and their use as antitumor agents
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
GB9806409D0 (en) Processes for preparing intermediates
YU48200A (sh) Farmaceutski preparati

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase